Showing results (31-40 of 312) with videos related to
Sort By:
Pageof 32
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2014
Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trialChris T Longenecker, Corrilynn O Hileman, Nicholas T Funderburg, et al.Advances in Therapy|August 14, 2021
Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United StatesGrace A McComsey, Melissa Lingohr-Smith, Rachel Rogers, et al.Pediatrics|December 3, 2005
First reported case of Neisseria meningitidis periorbital cellulitis associated with meningitisDavid V Chand, Claudia K Hoyen, Ethan G Leonard, et al.Medicine|October 25, 2022
Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and controlChristian Mouchati, Vanessa El Kamari, Abdus Sattar, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2013
C-reactive protein predicts 96-week carotid intima media thickness progression in HIV-infected adults naive to antiretroviral therapyCorrilynn O Hileman, Chris T Longenecker, Teresa L Carman, et al.Frontiers in Immunology|August 1, 2026
Feeding the gut-immune axis: dietary, prebiotic, and probiotic strategies to target persistent inflammation in ART-treated HIV: a narrative reviewAaron A Fletcher, Ziad Koberssy, Joviane Daher, et al.Journal of the International AIDS Society|June 21, 2013
Metabolic complications and treatment of perinatally HIV-infected children and adolescentsLinda Barlow-Mosha, Allison Ross Eckard, Grace A McComsey, et al.HIV Clinical Trials|August 23, 2017
Soluble TWEAK may predict carotid atherosclerosis in treated HIV infectionSahera Dirajlal-Fargo, Abdus Sattar, Manjusha Kulkarni, et al.Diabetes Care|July 29, 2010
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapyTodd T Brown, Katherine Tassiopoulos, Ronald J Bosch, et al.Antiviral Therapy|October 26, 2011
Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimensTodd T Brown, Allison C Ross, Norma Storer, et al.Pageof 32